Clinical Trial Update: IMPACT- 24Bt Post Mech. Thrombectomy and/or rtPA TRIAL IMPlant Augmenting Cerebral Blood Flow 24 Hours From Stroke Onset [Phase 3]

View source ↗

Summary

Phase 3 IMPACT-24Bt trial testing an implant to augment cerebral blood flow 24 hours after ischemic stroke (post-mechanical thrombectomy and/or rtPA) has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• IMPlant Augmenting Cerebral Blood Flow Implant

Snippet

Sponsor: BrainsGate | Conditions: Ischemic Stroke | Phase 3 | Status: TERMINATED